Rockland Trust Co. reduced its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 5.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 167,801 shares of the company's stock after selling 10,348 shares during the quarter. Rockland Trust Co.'s holdings in Colgate-Palmolive were worth $15,255,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. FMR LLC grew its holdings in shares of Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. Barclays PLC grew its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares in the last quarter. State Street Corp increased its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the last quarter. Nordea Investment Management AB raised its position in shares of Colgate-Palmolive by 32.5% during the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company's stock valued at $462,121,000 after buying an additional 1,247,731 shares in the last quarter. Finally, AQR Capital Management LLC grew its position in Colgate-Palmolive by 58.6% in the second quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company's stock worth $234,540,000 after acquiring an additional 892,706 shares in the last quarter. Institutional investors own 80.41% of the company's stock.
Insiders Place Their Bets
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.37% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the company. Stifel Nicolaus downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. Finally, Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $103.63.
Check Out Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive Stock Up 0.3 %
NYSE:CL traded up $0.23 during trading hours on Wednesday, reaching $87.90. The company's stock had a trading volume of 5,125,300 shares, compared to its average volume of 5,203,934. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The company has a market capitalization of $71.82 billion, a P/E ratio of 25.19, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. The stock has a 50 day moving average price of $92.36 and a two-hundred day moving average price of $97.92. Colgate-Palmolive has a 12 month low of $79.69 and a 12 month high of $109.30.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report